ARS Pharmaceuticals, Inc.

SPRY

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001671858

SEC filings (opens in a new tab)

No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding ARS Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of SPRY: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	115	2	151	+38
Shares	62.6M	4.13M	64.1M	+5.59M (+9.6%)
Value	$533.0M	$35.5M	$928.4M	+$430.8M (+86.6%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (50)

Institutions that held ARS Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to SPRY in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	4,245,974	$61.6M	0.00%
First Turn Management, LLC	593,291	$8.60M	1.36%
Duquesne Family Office LLCSuperinvestorDuquesne Family Office	536,900	$7.79M	0.27%
Millennium Management LLC	486,746	$7.06M	0.01%
Miura Global Management, LLC	270,000	$3.92M	4.50%
EAM Investors, LLC	261,649	$3.79M	0.57%
Wexford Capital LP	248,347	$3.60M	0.86%
Neuberger Berman Group LLC	245,935	$3.57M	0.00%
Raymond James & Associates	204,783	$2.97M	0.00%
Nicholas Investment Partners, LP	201,771	$2.93M	0.27%
Allspring Global Investments Holdings, LLC	178,221	$2.58M	0.00%
Alyeska Investment Group, L.P.	125,000	$1.81M	0.01%
Brandywine Global Investment Management, LLC	106,400	$1.59M	0.01%
Cambridge Investment Research Advisors, Inc.	87,158	$1.26M	0.00%
Trexquant Investment LP	85,295	$1.24M	0.02%
Valley Forge Investment Consultants Inc Adv	83,225	$1.21M	0.42%
Marshall Wace, LLP	77,879	$1.13M	0.00%
Connor, Clark & Lunn Investment Management Ltd.	77,208	$1.12M	0.01%
Caption Management, LLC	64,700	$938.1K	0.10%
TD Asset Management Inc	60,200	$862.1K	0.00%
Simplex Trading, LLC	55,615	$806.0K	0.03%
Group One Trading, L.P.	50,491	$732.1K	0.03%
Qube Research & Technologies Ltd	39,696	$575.6K	0.00%
Ancora Advisors, LLC	35,000	$507.5K	0.01%
Squarepoint Ops LLC	33,981	$492.7K	0.00%
Mariner, LLC	33,936	$492.1K	0.00%
Brevan Howard Capital Management LP	32,921	$477.4K	0.02%
Ameriprise Financial Inc	32,448	$470.5K	0.00%
Legato Capital Management LLC	24,352	$353.1K	0.04%
STRS Ohio	24,000	$348.0K	0.00%
Campbell & CO Investment Adviser LLC	21,446	$311.0K	0.02%
XTX Topco Ltd	17,243	$250.0K	0.02%
Intech Investment Management LLC	16,494	$239.2K	0.00%
ProShare Advisors LLC	15,027	$217.9K	0.00%
Stifel Financial Corp	13,746	$199.3K	0.00%
TFG Advisers LLC	12,399	$179.8K	0.06%
Quarry LP	12,000	$174.0K	0.05%
Arizona State Retirement System	11,160	$161.8K	0.00%
Acadian Asset Management LLC	4,009	$58.0K	0.00%
nVerses Capital, LLC	2,100	$30.4K	0.01%
Catalyst Funds Management Pty Ltd	2,000	$29.0K	0.01%
Avion Wealth	500	$7.00K	0.00%
Brown, Lisle/Cummings, Inc.	400	$5.80K	0.00%
Bessemer Group Inc	255	$4.00K	0.00%
Pension & Wealth Management Advisors, Inc.	73	$1.07K	0.00%
Sterling Capital Management LLC	51	$740	0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	50	$725	0.00%
Capital Performance Advisors LLP	33	$479	0.00%
Farther Finance Advisors, LLC	6	$87	0.00%
National Bank of Canada	1	$14	0.00%

Sold out (12)

Institutions that held ARS Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of SPRY in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Perceptive Advisors LLC	867,319	$7.38M
Rubric Capital Management LP	639,203	$5.44M
Sio Capital Management, LLC	217,864	$1.85M
Walleye Capital LLC	71,499	$608.5K
Avantax Planning Partners, Inc.	32,174	$273.8K
Schonfeld Strategic Advisors LLC	27,139	$231.0K
Los Angeles Capital Management LLC	27,120	$230.8K
Alpine Global Management, LLC	23,435	$199.4K
Arrowstreet Capital, Limited Partnership	14,967	$127.0K
Voloridge Investment Management, LLC	10,388	$88.4K
Principal Financial Group Inc	10,230	$87.1K
Pacer Advisors, Inc.	485	$4.13K

Not filed for Q3 2024 yet (2)

Institutions that held ARS Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SPRY in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	4,084,339	$34.8M
Permanent Capital Management, LP	42,623	$743.8K